Showing results (341-350 of 387) with videos related to
Sort By:
Pageof 39
British Heart Journal|May 1, 1988
Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The NetherlandsF Vermeer, M L Simoons, C de Zwaan, et al.Circulation|March 14, 1998
Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-IK W Mahaffey, C B Granger, M A Sloan, et al.Journal of Virological Methods|September 1, 1989
The use of peroxidase anti-peroxidase (PAP) complexes in the detection of plant viruses by ELISAG F Rowland, D J Engelbrecht, E J Pool, et al.Journal of Cardiovascular Pharmacology|July 1, 1985
Pharmacokinetics and pharmacodynamics of enalapril in patients with congestive heart failure and patients with hypertensionJ B Schwartz, A Taylor, D Abernethy, et al.American Heart Journal|September 1, 1999
Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary ArteriesK W Mahaffey, C B Granger, M A Sloan, et al.European Heart Journal|February 10, 2000
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUITK M Akkerhuis, J W Deckers, E Boersma, et al.Heart (British Cardiac Society)|March 17, 2001
Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplastyK M Akkerhuis, M J van Den Brand, C van Der Zwaan, et al.Circulation|March 7, 1998
Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic InvestigatorsS G Goodman, A Langer, A M Ross, et al.International Journal of Sports Medicine|June 22, 1999
The effects of B-sitosterol (BSS) and B-sitosterol glucoside (BSSG) mixture on selected immune parameters of marathon runners: inhibition of post marathon immune suppression and inflammationP J Bouic, A Clark, J Lamprecht, et al.European Journal of Immunology|November 1, 1996
Conservation of minor histocompatibility antigens between human and non-human primatesJ M den Haan, R E Bontrop, J Pool, et al.Pageof 39